A citation-based method for searching scientific literature

Thiago Junqueira Ribeiro Rezende, Jean Levi Ribeiro de Paiva, Alberto Rolim Muro Martinez, Iscia Lopes-Cendes, José Luiz Pedroso, Orlando Graziani Povoas Barsottini, Fernando Cendes, Marcondes C França. Ann Neurol 2018
Times Cited: 37







List of co-cited articles
359 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Scale for the assessment and rating of ataxia: development of a new clinical scale.
T Schmitz-Hübsch, S Tezenas du Montcel, L Baliko, J Berciano, S Boesch, C Depondt, P Giunti, C Globas, J Infante, J-S Kang,[...]. Neurology 2006
941
51

Genotype-specific patterns of atrophy progression are more sensitive than clinical decline in SCA1, SCA3 and SCA6.
Kathrin Reetz, Ana S Costa, Shahram Mirzazade, Anna Lehmann, Agnes Juzek, Maria Rakowicz, Romana Boguslawska, Ludger Schöls, Christoph Linnemann, Caterina Mariotti,[...]. Brain 2013
86
40

Spinocerebellar ataxia.
Thomas Klockgether, Caterina Mariotti, Henry L Paulson. Nat Rev Dis Primers 2019
136
37

A multimodal evaluation of microstructural white matter damage in spinocerebellar ataxia type 3.
Rachel P Guimarães, Anelyssa D'Abreu, Clarissa L Yasuda, Marcondes C França, Beatriz H B Silva, Fabio A M Cappabianco, Felipe P G Bergo, Iscia T Lopes-Cendes, Fernando Cendes. Mov Disord 2013
51
35

Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data.
Heike Jacobi, Kathrin Reetz, Sophie Tezenas du Montcel, Peter Bauer, Caterina Mariotti, Lorenzo Nanetti, Maria Rakowicz, Anna Sulek, Alexandra Durr, Perrine Charles,[...]. Lancet Neurol 2013
108
35

Visualization, quantification and correlation of brain atrophy with clinical symptoms in spinocerebellar ataxia types 1, 3 and 6.
Jörg B Schulz, Johannes Borkert, Stefanie Wolf, Tanja Schmitz-Hübsch, Maryla Rakowicz, Caterina Mariotti, Ludger Schöls, Dagmar Timmann, Bart van de Warrenburg, Alexandra Dürr,[...]. Neuroimage 2010
111
29

Spinocerebellar ataxias: prospects and challenges for therapy development.
Tetsuo Ashizawa, Gülin Öz, Henry L Paulson. Nat Rev Neurol 2018
80
29

Autosomal dominant cerebellar ataxias: Imaging biomarkers with high effect sizes.
Isaac M Adanyeguh, Vincent Perlbarg, Pierre-Gilles Henry, Daisy Rinaldi, Elodie Petit, Romain Valabregue, Alexis Brice, Alexandra Durr, Fanny Mochel. Neuroimage Clin 2018
39
29

White matter damage is related to ataxia severity in SCA3.
J-S Kang, J C Klein, S Baudrexel, R Deichmann, D Nolte, R Hilker. J Neurol 2014
31
35

The preclinical stage of spinocerebellar ataxias.
Roderick P P W M Maas, Judith van Gaalen, Thomas Klockgether, Bart P C van de Warrenburg. Neurology 2015
56
29

Brain atrophy measures in preclinical and manifest spinocerebellar ataxia type 2.
Kathrin Reetz, Roberto Rodríguez-Labrada, Imis Dogan, Shahram Mirzazade, Sandro Romanzetti, Jörg B Schulz, Edilia M Cruz-Rivas, Jose A Alvarez-Cuesta, Raul Aguilera Rodríguez, Yanetza Gonzalez Zaldivar,[...]. Ann Clin Transl Neurol 2018
26
38

Neurochemical abnormalities in premanifest and early spinocerebellar ataxias.
James M Joers, Dinesh K Deelchand, Tianmeng Lyu, Uzay E Emir, Diane Hutter, Christopher M Gomez, Khalaf O Bushara, Lynn E Eberly, Gülin Öz. Ann Neurol 2018
38
27

Neocortical atrophy in Machado-Joseph disease: a longitudinal neuroimaging study.
Anelyssa D'Abreu, Marcondes C França, Clarissa L Yasuda, Bruno A G Campos, Iscia Lopes-Cendes, Fernando Cendes. J Neuroimaging 2012
56
24

Structural and functional MRI abnormalities of cerebellar cortex and nuclei in SCA3, SCA6 and Friedreich's ataxia.
Maria R Stefanescu, Moritz Dohnalek, Stefan Maderwald, Markus Thürling, Martina Minnerop, Andreas Beck, Marc Schlamann, Joern Diedrichsen, Mark E Ladd, Dagmar Timmann. Brain 2015
58
24

Clinical features, neurogenetics and neuropathology of the polyglutamine spinocerebellar ataxias type 1, 2, 3, 6 and 7.
Udo Rüb, Ludger Schöls, Henry Paulson, Georg Auburger, Pawel Kermer, Joanna C Jen, Kay Seidel, Horst-Werner Korf, Thomas Deller. Prog Neurobiol 2013
177
24

Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study.
Heike Jacobi, Sophie Tezenas du Montcel, Peter Bauer, Paola Giunti, Arron Cook, Robyn Labrum, Michael H Parkinson, Alexandra Durr, Alexis Brice, Perrine Charles,[...]. Lancet Neurol 2015
116
24

Microstructural Alterations in Asymptomatic and Symptomatic Patients with Spinocerebellar Ataxia Type 3: A Tract-Based Spatial Statistics Study.
Xinwei Wu, Xinxin Liao, Yafeng Zhan, Cheng Cheng, Wei Shen, Mufang Huang, Zhifan Zhou, Zheng Wang, Zilong Qiu, Wu Xing,[...]. Front Neurol 2017
13
61

CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1.
Y Kawaguchi, T Okamoto, M Taniwaki, M Aizawa, M Inoue, S Katayama, H Kawakami, S Nakamura, M Nishimura, I Akiguchi. Nat Genet 1994
21

Dissociation of grey and white matter reduction in spinocerebellar ataxia type 3 and 6: a voxel-based morphometry study.
Carsten Lukas, Ludger Schöls, Barbara Bellenberg, Udo Rüb, Horst Przuntek, Gebhard Schmid, Odo Köster, Boris Suchan. Neurosci Lett 2006
55
21

Axonal dysfunction in the deep white matter in Machado-Joseph disease.
Anelyssa D'Abreu, Marcondes França, Simone Appenzeller, Iscia Lopes-Cendes, Fernando Cendes. J Neuroimaging 2009
26
30

Brain pathology of spinocerebellar ataxias.
Kay Seidel, Sonny Siswanto, Ewout R P Brunt, Wilfred den Dunnen, Horst-Werner Korf, Udo Rüb. Acta Neuropathol 2012
214
21

Prediction of the age at onset in spinocerebellar ataxia type 1, 2, 3 and 6.
Sophie Tezenas du Montcel, Alexandra Durr, Maria Rakowicz, Lorenzo Nanetti, Perrine Charles, Anna Sulek, Caterina Mariotti, Rafal Rola, Ludger Schols, Peter Bauer,[...]. J Med Genet 2014
42
21

Gray matter volume deficits in spinocerebellar ataxia: an optimized voxel based morphometric study.
Gaurav Goel, Pramod Kumar Pal, Shivashankar Ravishankar, Ganesan Venkatasubramanian, Peruvumba N Jayakumar, Nithin Krishna, Meera Purushottam, Jitender Saini, Mohammed Faruq, Mitali Mukherji,[...]. Parkinsonism Relat Disord 2011
44
18

International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology Committee of the World Federation of Neurology.
P Trouillas, T Takayanagi, M Hallett, R D Currier, S H Subramony, K Wessel, A Bryer, H C Diener, S Massaquoi, C M Gomez,[...]. J Neurol Sci 1997
890
18


In vivo neurometabolic profiling in patients with spinocerebellar ataxia types 1, 2, 3, and 7.
Isaac M Adanyeguh, Pierre-Gilles Henry, Tra M Nguyen, Daisy Rinaldi, Celine Jauffret, Romain Valabregue, Uzay E Emir, Dinesh K Deelchand, Alexis Brice, Lynn E Eberly,[...]. Mov Disord 2015
41
18

Structural signature in SCA1: clinical correlates, determinants and natural history.
Carlos Roberto Martins Junior, Alberto Rolim Muro Martinez, Ingrid Faber Vasconcelos, Thiago Junqueira Ribeiro de Rezende, Raphael Fernandes Casseb, Jose Luiz Pedroso, Orlando Graziani Povoas Barsottini, Íscia Lopes-Cendes, Marcondes Cavalcante França. J Neurol 2018
9
77

The natural history of spinocerebellar ataxia type 1, 2, 3, and 6: a 2-year follow-up study.
H Jacobi, P Bauer, P Giunti, R Labrum, M G Sweeney, P Charles, A Dürr, C Marelli, C Globas, C Linnemann,[...]. Neurology 2011
121
18

Gene-Related Cerebellar Neurodegeneration in SCA3/MJD: A Case-Controlled Imaging-Genetic Study.
Huirong Peng, Xiaochun Liang, Zhe Long, Zhao Chen, Yuting Shi, Kun Xia, Li Meng, Beisha Tang, Rong Qiu, Hong Jiang. Front Neurol 2019
11
63

Inventory of Non-Ataxia Signs (INAS): validation of a new clinical assessment instrument.
H Jacobi, M Rakowicz, R Rola, R Fancellu, C Mariotti, P Charles, A Dürr, M Küper, D Timmann, C Linnemann,[...]. Cerebellum 2013
59
18

SCA3: neurological features, pathogenesis and animal models.
Olaf Riess, Udo Rüb, Annalisa Pastore, Peter Bauer, Ludger Schöls. Cerebellum 2008
149
16

Brainstem neurodegeneration correlates with clinical dysfunction in SCA1 but not in SCA2. A quantitative volumetric, diffusion and proton spectroscopy MR study.
L Guerrini, F Lolli, A Ginestroni, G Belli, R Della Nave, C Tessa, S Foresti, M Cosottini, S Piacentini, F Salvi,[...]. Brain 2004
78
16

Autosomal dominant cerebellar ataxia type I. MRI-based volumetry of posterior fossa structures and basal ganglia in spinocerebellar ataxia types 1, 2 and 3.
T Klockgether, M Skalej, D Wedekind, A R Luft, D Welte, J B Schulz, M Abele, K Bürk, F Laccone, A Brice,[...]. Brain 1998
132
16

Spinal cord damage in Machado-Joseph disease.
Camila N Fahl, Lucas Melo T Branco, Felipe P G Bergo, Anelyssa D'Abreu, Iscia Lopes-Cendes, Marcondes C França. Cerebellum 2015
18
33

CAG repeat length does not associate with the rate of cerebellar degeneration in spinocerebellar ataxia type 3.
Shang-Ran Huang, Yu-Te Wu, Chii-Wen Jao, Bing-Wen Soong, Jiing-Feng Lirng, Hsiu-Mei Wu, Po-Shan Wang. Neuroimage Clin 2016
12
50

Spinocerebellar ataxia 3 and Machado-Joseph disease: clinical, molecular, and neuropathological features.
A Dürr, G Stevanin, G Cancel, C Duyckaerts, N Abbas, O Didierjean, H Chneiweiss, A Benomar, O Lyon-Caen, J Julien,[...]. Ann Neurol 1996
337
16

Toward understanding Machado-Joseph disease.
Maria do Carmo Costa, Henry L Paulson. Prog Neurobiol 2012
158
16

Oligonucleotide therapy mitigates disease in spinocerebellar ataxia type 3 mice.
Hayley S McLoughlin, Lauren R Moore, Ravi Chopra, Robert Komlo, Megan McKenzie, Kate G Blumenstein, Hien Zhao, Holly B Kordasiewicz, Vikram G Shakkottai, Henry L Paulson. Ann Neurol 2018
67
16

Pathoanatomy of cerebellar degeneration in spinocerebellar ataxia type 2 (SCA2) and type 3 (SCA3).
W Scherzed, E R Brunt, H Heinsen, R A de Vos, K Seidel, K Bürk, L Schöls, G Auburger, D Del Turco, T Deller,[...]. Cerebellum 2012
58
16

The global epidemiology of hereditary ataxia and spastic paraplegia: a systematic review of prevalence studies.
Luis Ruano, Claudia Melo, M Carolina Silva, Paula Coutinho. Neuroepidemiology 2014
263
16

Sensitivity of Volumetric Magnetic Resonance Imaging and Magnetic Resonance Spectroscopy to Progression of Spinocerebellar Ataxia Type 1.
Dinesh K Deelchand, James M Joers, Adarsh Ravishankar, Tianmeng Lyu, Uzay E Emir, Diane Hutter, Christopher M Gomez, Khalaf O Bushara, Christophe Lenglet, Lynn E Eberly,[...]. Mov Disord Clin Pract 2019
8
75

Cerebral cortex involvement in Machado-Joseph disease.
T J R de Rezende, A D'Abreu, R P Guimarães, T M Lopes, I Lopes-Cendes, F Cendes, G Castellano, M C França. Eur J Neurol 2015
30
20

Spinocerebellar ataxia types 1, 2, 3, and 6: disease severity and nonataxia symptoms.
T Schmitz-Hübsch, M Coudert, P Bauer, P Giunti, C Globas, L Baliko, A Filla, C Mariotti, M Rakowicz, P Charles,[...]. Neurology 2008
168
16

Brain stem and cerebellum volumetric analysis of Machado Joseph disease patients.
Sarah Teixeira Camargos, Wilson Marques, Antonio Carlos dos Santos. Arq Neuropsiquiatr 2011
13
38

Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis.
Ludger Schöls, Peter Bauer, Thorsten Schmidt, Thorsten Schulte, Olaf Riess. Lancet Neurol 2004
657
13

Quantitative assessment of brain stem and cerebellar atrophy in spinocerebellar ataxia types 3 and 6: impact on clinical status.
L Eichler, B Bellenberg, H K Hahn, O Köster, L Schöls, C Lukas. AJNR Am J Neuroradiol 2011
39
13

MR Imaging in Spinocerebellar Ataxias: A Systematic Review.
A Klaes, E Reckziegel, M C Franca, T J R Rezende, L M Vedolin, L B Jardim, J A Saute. AJNR Am J Neuroradiol 2016
21
23

Polyglutamine spinocerebellar ataxias - from genes to potential treatments.
Henry L Paulson, Vikram G Shakkottai, H Brent Clark, Harry T Orr. Nat Rev Neurosci 2017
136
13

Cytokines in Machado Joseph Disease/Spinocerebellar Ataxia 3.
Gerson da Silva Carvalho, Jonas Alex Morales Saute, Clarissa Branco Haas, Vitor Rocco Torrez, Andressa Wigner Brochier, Gabriele Nunes Souza, Gabriel Vasata Furtado, Tailise Gheno, Aline Russo, Thais Lampert Monte,[...]. Cerebellum 2016
18
27

Machado-Joseph disease gene product is a cytoplasmic protein widely expressed in brain.
H L Paulson, S S Das, P B Crino, M K Perez, S C Patel, D Gotsdiner, K H Fischbeck, R N Pittman. Ann Neurol 1997
217
13


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.